Interestingly, we observed marked upregulation of a series of immune checkpoint genes including VISR, TNFRSF14, NECTIN2, CD40, CD86, CD276, HAVCR2, and LGALS9 in most tumor-infiltrating myeloid cells (Fig. 5h). This evidence concerns the gene CD86 and neoplasm.